BERMILY MALDONADO-COLON

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology LAKELAND, FL NPI 1790969749

General Payments — all program years on this page

$4,150.17

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 187
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $500.33 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $475.7219
Education $24.611

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $708.4235
2019 $714.6635
2020 $288.1315
2021 $594.4823
2022 $670.6929
2023 $673.4630
2024 $500.3320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086164886 Bayer Healthcare Pharmaceuticals Inc. $21.70 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086170946 Bayer Healthcare Pharmaceuticals Inc. $23.97 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086210705 Bayer Healthcare Pharmaceuticals Inc. $20.84 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087153688 Novartis Pharmaceuticals Corporation $30.49 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087153690 Novartis Pharmaceuticals Corporation $32.45 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087153692 Novartis Pharmaceuticals Corporation $34.59 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104586668 AstraZeneca Pharmaceuticals LP $26.86 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104759566 AstraZeneca Pharmaceuticals LP $24.52 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112846882 OPKO Pharmaceuticals, LLC $18.62 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118158207 Boehringer Ingelheim Pharmaceuticals, Inc. $17.97 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118158209 Boehringer Ingelheim Pharmaceuticals, Inc. $19.44 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118158211 Boehringer Ingelheim Pharmaceuticals, Inc. $21.45 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118934496 Otsuka America Pharmaceutical, Inc. $24.43 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124047866 Vifor Pharma, Inc. $23.30 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145102758 Mallinckrodt Hospital Products Inc. $25.28 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145102762 Mallinckrodt Hospital Products Inc. $26.89 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145102766 Mallinckrodt Hospital Products Inc. $31.11 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145830377 AKEBIA THERAPEUTICS INC $28.00 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145834303 AKEBIA THERAPEUTICS INC $24.61 11/11/2024 Education Undisputed 01/23/2026 View at CMS
1150686765 Aurinia Pharma U.S., Inc. $23.81 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.